APAC Lung Cancer Therapeutics Market, Market Segmented, by Treatment Type (Chemotherapy, Radiotherapy, and Other Drugs) - Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138304
- Pages: 200
-
Format:
Report Overview
The APAC Lung Cancer Therapeutics Market, market size stood at around USD $1.09 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Lung cancer accounts for a greater share of the whole number of patients suffering from cancer. Small cell lung cancer type is dangerous due to the fact that there are no drugs present for its treatment and that the smaller size of cancer cells present in this type of cancer makes it harder to be treated even by surgical involvement
Market Drivers
The APAC lung cancer therapeutics market is expected to observe profitable growth in the coming years largely due to the stable increase in the occurrence of cancer cases. As the geriatric population is likely to increase, the incidence of lung cancer is predicted to rise, thus acting as a driver for revenue growth. Lack of awareness among patients and side effects associated with the treatment therapies are expected to obstruct the growth of APAC lung cancer therapeutics market
1. APAC Lung Cancer Therapeutics Market Overview
A. Market Size
2. APAC Lung Cancer Therapeutics Growth Drivers and Restraints
A. Stable increase in the occurrence of cancer cases
B. Geriatric population is likely to increase, the incidence of lung cancer
C. Lack of awareness among patients and side effects associated with the treatment therapies
3. APAC Lung Cancer Therapeutics Market Segmentation
A. By Treatment Type
I. Chemotherapy
II. Radiotherapy
III. Other Drugs
4. Lung Cancer Therapeutics Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Hoffman-La Roche, Company overview, Product & Services, Strategies & Financials
B. Pfizer Inc, Company overview, Product & Services, Strategies & Financials
C. GlaxoSmithKline, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
